What is the Buying Price of Alembic Pharmaceuticals Share?

The Buying Price of Alembic Pharmaceuticals share is 763 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

How to buy Alembic Pharmaceuticals Share at Choice?

To buy Alembic Pharmaceuticals stocks , log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Alembic Pharmaceuticals, choose your preferred order type, and place the trade.

What is the PE ratio of Alembic Pharmaceuticals Shares?

The Price-to-earnings (P/E) ratio of Alembic Pharmaceuticals shares is 22.19. You can compare it with the sector average for relative valuation.

What is the PB ratio of Alembic Pharmaceuticals Shares?

The Price to Book (P/B) ratio Alembic Pharmaceuticals shares is 2.64. Useful to assess the stock's value relative to its book value.

Is Alembic Pharmaceuticals Overvalued?

To assess Alembic Pharmaceuticals’s valuation compare Sector P/E, P/B which are 69.22 & 3.07 with sector averages, along with growth rates and financial metrics.

What is the Market Cap of Alembic Pharmaceuticals?

The Market Cap of Alembic Pharmaceuticals is 14997.77 CR. It indicates the company's size category and trading liquidity.

What is the 52 Week High and Low of Alembic Pharmaceuticals Share Price?

The 52 week high and low prices of Alembic Pharmaceuticals share price is 1107.9 & 635.8. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Which sector does Alembic Pharmaceuticals belong to?

Alembic Pharmaceuticals belongs to the Healthcare sector.

Alembic Pharmaceuticals Share price

APLLTD

Healthcare Large Cap

763

13.30 (1.77%)

NSE

BSE

Last updated on 19 Jun, 2026 | 15:40 IST

BuySell

Today's High

768.80

Today's Low

744.35

52 Week Low

635.80

52 Week High

1107.90

Alembic Pharmaceuticals Chart

ChartIQ

TradingView

Alembic Pharmaceuticals Share Key Metrics

Volume

2.79 L

Market Cap

14997.77 CR

LTQ@LTP

5@763.00

ATP

760.16 Var Margin

16.19 %

Circuit Range

599.8-899.6

Delivery %

37.79 %

Value

21.23 CR

ASM/GSM

No

Market Lot

1

Summary

19 Jun, 2026 | 15:40 को, Alembic Pharmaceuticals का शेयर प्राइस आज ₹763 पर है, जो दिन के लिए 13.30% की 1.77 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹744.35 और ₹768.80 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹635.80 से ₹1107.90 तक रही है। ट्रेडिंग गतिविधि के मामले में, Alembic Pharmaceuticals ने 279321 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹196563124 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹76016 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 5,76300 रही। यह स्टॉक ₹599.8-899.6 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹21.23 CR है। दिन के लिए डिलीवरी परसेंटेज 37.79% रही। इसके अतिरिक्त, Alembic Pharmaceuticals वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Alembic Pharmaceuticals Fundamentals

P/E Ratio

22.19

P/B Ratio

2.64

Div. Yield

1.58

Sector P/E

69.22

Sector P/B

3.07

Sec. Div. Yield

0.53

Alembic Pharmaceuticals Resistance and Support

Pivot 748.23

Resistance

First Resistance

754.46

Second Resistance

759.23

Third Resistance

765.46

Support

First Support

743.46

Second Support

737.23

Third Support

732.46

Alembic Pharmaceuticals Shareholding Pattern

2016-17
2018-19
2019-20
2020-21
2021-22
2022-23
2023-24
2024-25
2025-26
2026-27

Total Promoters

Segment

Percent

Total Promoters

69.74%

Mutual Fund

8.18%

Insurance

7.68%

Foreign Institutional Investors

4.26%

Domestic Institutional Investors

0.31%

Retail

9.83%

Others

0%

Total Promoters

MAR '26

69.74%

Alembic Pharmaceuticals Corporate Actions

Date	Agenda
2026-05-15	Audited Results & Final Dividend
2026-02-05	Quarterly Results

Alembic Pharmaceuticals News

Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Alembic Pharmaceuticals has scheduled one-on-one investor meetings with institutional investors, including HDFC Mutual Fund, Tata Mutual Fund, DSP Mutual Fund, and HDFC Life Insurance Company Limited, on June 22, 23, and 25, 2026. These meetings are for general discussions, with no unpublished price sensitive information to be shared.

Jun 19 2026 17:10:13

Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Alembic Pharmaceuticals has scheduled one-on-one investor meetings with institutional investors, including HDFC Mutual Fund, Tata Mutual Fund, DSP Mutual Fund, and HDFC Life Insurance Company Limited, on June 22, 23, and 25, 2026. These meetings are for general discussions, with no unpublished price sensitive information to be shared.

Jun 19 2026 17:08:02

Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Alembic Pharmaceuticals has scheduled one-on-one investor meetings with institutional investors, including HDFC Mutual Fund, Tata Mutual Fund, DSP Mutual Fund, and HDFC Life Insurance Company Limited, on June 22, 23, and 25, 2026. These meetings are for general discussions, with no unpublished price sensitive information to be shared.

Jun 19 2026 17:04:18

Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Alembic Pharmaceuticals received USFDA tentative approval for Binimetinib Tablets, 45 mg. This approval targets an estimated market size of US$259 million and positions the company for generic marketing exclusivity.

Jun 19 2026 12:57:13

Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Alembic Pharma received USFDA final approval for its Tretinoin Cream USP, 0.05% for acne treatment. This product targets an estimated US$76 million market by March 2026, adding to the company's 222 final ANDA approvals.

Jun 12 2026 12:45:03

Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Alembic Pharma secured USFDA tentative approval for Larotrectinib Capsules (25 mg & 100 mg). This targets a US$91 million market and grants potential for 180 days of generic marketing exclusivity in the U.S. The company is the sole first applicant for this ANDA.

Jun 11 2026 12:35:47

Alembic Pharmaceuticals Ltd - 533573 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Alembic Pharma has entered into a joint venture with Difgen Holdings LLC to establish a new Canadian corporation. This venture aims to develop, commercialize, and market pharmaceutical products in the Canadian market, with Alembic holding a 45% equity stake.

Jun 06 2026 16:05:12

Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Alembic Pharmaceuticals received USFDA final approval for its Haloperidol Tablets, USP. This approval opens access to an estimated US$27 million market for the twelve months ending March 2026, strengthening the company's US generics presence.

Jun 05 2026 10:52:15

Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Alembic Pharmaceuticals received USFDA final approval for its Abbreviated New Drug Application (ANDA) for Levothyroxine Sodium Tablets USP. This drug targets an estimated market size of US$1,869 million over the next twelve months.

May 22 2026 10:59:06

Name	Position
Chirayu Amin	Chairman & CEO
Pranav Amin	Managing Director

Alembic Pharmaceuticals Similar Stocks

Cohance Lifesciences Ltd.

405.85

-7.95 (1.92%)

Jubilant Pharmova Ltd.

966.35

-7.10 (0.73%)

Poly Medicure Ltd.

1563.30

-9.90 (0.63%)

Natco Pharma Ltd.

889.00

5.50 (0.62%)

Rainbow Children's Medicare Ltd.

1470.80

20.80 (1.43%)

Dr. Agarwal's Health Care Ltd.

466.65

21.85 (4.91%)

Concord Biotech Ltd.

1315.10

-32.40 (2.40%)

Vijaya Diagnostic Centre Ltd.

1364.20

58.60 (4.49%)

Alivus Life Sciences Ltd.

1070.30

10.30 (0.97%)

Alembic Pharmaceuticals FAQs

Alembic Pharmaceuticals शेयर का खरीद मूल्य 763 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Alembic Pharmaceuticals शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Alembic Pharmaceuticals शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 22.19 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Alembic Pharmaceuticals शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 2.64 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Alembic Pharmaceuticals शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.07 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Alembic Pharmaceuticals का मार्केट कैप 14997.77 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Alembic Pharmaceuticals शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 1107.90 और 635.80 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।